THE SYSTEMIC INFLAMMATORY RESPONSE IDENTIFIES PATIENTS WITH ADVERSE CLINICAL OUTCOME FROM IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA

Ambreen Muhammed  1     Matthias Pinter  2     Bernhard Scheiner  2     Lorenz Balcar  2     Thomas Marron  3     Tomi Jun  3     Sirish Sirish Dharmapuri  3     Celina Ang  3     Anwaar Saeed  4     Hannah Hildebrand  4     Musharraf Navaid  5     Anushi Bulumulle  5     Mahvish Muzaffar  5     Abdul Rafeh Naqash  5     Anuhya Gampa  6     Anjana Pillai  6     Yinghong Wang  7     Uqba Khan  8     Pei-Chang Lee  9     Yi-Hsiang Huang  9     Dominik Bettinger  10     Yehia I. Abugabal  10     Ahmed Kaseb  10     Tiziana Pressiani  11     Nicola Personeni  12     Lorenza Rimassa  12     Naoshi Nishida  13     Masatoshi Kudo  13     Arndt Vogel  14     Alessio Cortellini  14     Rohini Sharma  14     David Pinato  14    
1 Imperial College London, London, United Kingdom
2 Medical University Vienna, Wien, Austria
3 Mount Sinai Hospital, New York, United States
4 Kansas University Cancer Center, Kansas, United States
5 East Carolina University, Greenville, United States
6 University of Chicago Medicine, Chicago, United States
7 The University of Texas MD Anderson Cancer Center, Houston, United States
8 Weill Cornell Medicine/New York Presbyterian Hospital, New York, United States
9 Taipei Veterans General Hospital, Taipei, Taiwan
10 University of Freiburg, Freiburg, Germany
11 Humanitas Clinical and Research Center - IRCCS, Milan, Italy
12 Humanitas University, Milan, Italy
13 Kindai University Faculty of Medicine, Osaka, Japan
14 Medizin. Hochschule Hannover, Hannover, Germany

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing